Pharmadrug Inc.
PHRX
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -26.14% | 73.79% | 95.56% | -3,942.33% | 28.44% |
| Total Depreciation and Amortization | 0.00% | -1.08% | -51.81% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -63.64% |
| Total Other Non-Cash Items | -3.49% | 37.90% | -99.22% | 12,555.54% | -34.50% |
| Change in Net Operating Assets | 117.08% | -85.59% | -136.93% | 590.42% | -67.96% |
| Cash from Operations | 95.32% | 62.91% | -3,347.01% | 90.12% | -22.31% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -103.33% | -78.72% |
| Cash from Investing | -- | -- | -- | 8,980.00% | -78.72% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -26.17% | 4,511.76% |
| Cash from Financing | -- | -- | 45.84% | -25.88% | 222.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -14.29% | 75.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 95.32% | 7.37% | -154.91% | 162.59% | 9,233.33% |
